(Press-News.org) A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor cells circulating in the blood indicates whether a patient with lung cancer will experience a lasting response to a newly approved immunotherapy called tarlatamab. The findings, which are published in Cancer Discovery, could allow clinicians to easily and noninvasively determine which patients should receive the drug.
“Isolating cancer cells from the blood has tremendous potential to guide immune-related cancer therapies, and our group has created cutting edge bioengineering technologies for purification of these circulating tumor cells,” said senior and co-corresponding author Daniel A. Haber, MD, PhD, director of the Krantz Family Center for Cancer Research at the Mass General Brigham Cancer Institute. “We’ve learned a lot about the biology of these cells, but we haven’t had a test that has direct clinical relevance. In this study, we believe that we achieved this.” The blood cell enrichment technology has been licensed to TellBio, Inc.
The study focused on whether properties of circulating tumor cells might correlate with a patient’s response to tarlatamab, which was fully approved in late 2025 as a treatment for small cell lung cancer (SCLC) after prior chemotherapy. Tarlatamab is an antibody that recruits T cells to cancer cells expressing a specific neuro-endocrine marker called DLL3.
Although tarlatamab showed promise in clinical trials, about half of patients with SCLC experience cancer progression within six months of initiating therapy. It was thought that every SCLC case expresses DLL3, but Haber and colleagues found that only half of the 20 patients they studied had abundant DLL3-positive cancer cells in their blood, and these were the patients who responded to tarlatamab. DLL3 testing on CTCs correctly identified 85% of patients who had a clinical benefit from the drug and 100% who did not (85% sensitivity, 100% specificity).
The study, which was a collaboration between bioengineering experts who had developed the technology to analyze rare cancer cells in blood specimens, and lung cancer clinicians, has important implications for clinical care.
“Our work may help predict which patients with SCLC are likely to respond to tarlatamab and potentially other antibodies targeting DLL3, many of which are in development,” said co-corresponding author Justin Gainor, MD, program director of the Center for Thoracic Cancers at the Mass General Brigham Cancer Institute. “It also has potential implications for other cancers that express DLL3 as they become more aggressive and for the field of antibody-directed cancer therapies.”
Authorship: In addition to Haber, Mass General Brigham authors include Avanish Mishra, Catherine B. Meadord, Kruthika Kikkeri, Quinn Cunneely, Maoxuan Lin, Tom LaSalle, Shih-Bo Huang, Remy Bell, Victor Putaturo, Weikun Xia, Joyce Liang, Jacy Fang, Sarah San Vicente, Caroline Zielinski, Subba R. Digumarthy, Yin P. Hung, Beow Y. Yeap, Jon Edd, Michael S. Lawrence, Moshe Sade-Feldman, Debattama Sen, Mehmet Toner, Shyamala Maheswaran, and Justin F. Gainor.
Paper cited: Mishra A, Meador CB, Kikkeri K, et al. “Circulating Tumor Cells Predict Response to the DLL3-targeting Bispecific Antibody Tarlatamab” Cancer Discovery DOI: 10.1158/2159-8290.CD-25-1483
###
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
SAN ANTONIO — January 14, 2026 — Southwest Research Institute’s (SwRI) Dr. Michael Davis has been named a Fellow of the Society of Photo-Optical Instrumentation Engineers (SPIE).
Davis is an astrophysicist who specializes in the design and testing of space instruments including those used for ultraviolet (UV) imaging and spectroscopy of remote planets, galactic astrophysics, and Earth’s plasmasphere. He was named a senior member of SPIE in 2021, and this latest honor puts him in the most elite category of membership.
Founded in 1955, SPIE promotes the global optics and photonics community through conferences, publications and professional ...
Exposure to “Forever Chemicals” Linked to Higher Risk of Gestational Diabetes, Major Review Finds
Largest and most comprehensive systematic review and meta-analysis to date links PFAS exposure to insulin resistance and altered insulin secretion, identifying pregnancy as a key vulnerable period
New York, NY (January 14, 2026) — Exposure to per- and polyfluoroalkyl substances (PFAS), a class of highly persistent environmental chemicals commonly referred to as “forever chemicals,” is associated with a higher risk of gestational diabetes mellitus and altered markers of insulin ...
Cambridge, Massachusetts, January 14, 2025 - Insilico Medicine (“Insilico”, HKEX:03696), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced the demonstration of its Nach01 multimodal foundation model deployed on Microsoft Discovery, Microsoft’s science-focused platform designed to accelerate research and development through agentic AI. This collaboration highlights Microsoft Discovery’s extensibility with third-party AI models and illustrates how R&D organizations can adopt unified, AI-native ...
Against the background of accelerated global warming, the atmospheric moisture content has increased significantly and the hydrological cycle has intensified, leading to pronounced rises in both the frequency and intensity of extreme precipitation events globally. Northeast China, a region highly sensitive to climate change, has experienced increasing occurrence of clustered extreme heavy precipitation events in recent years. Improved knowledge of synoptic regimes and moisture accumulation responsible for clustered extreme heavy precipitation events (CEPEs) is essential for enhancing short-term forecasting skill and disaster prevention and mitigation.
Researchers ...
A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the body. This is shown by a new study by researchers at Umeå University, Sweden. Systemic administration of the purified bacterial substance changes the immune microenvironment in tumours, and the results may open the way for research into a new type of cancer treatment.
"The substance not only kills cancer cells directly. It reshapes the tumour environment and helps the immune system to work against the tumor without damaging healthy tissue," says Sun Nyunt Wai, professor at Umeå University and one of the lead authors behind ...
A substance poisonous to humans — hydrogen cyanide — may have helped create the seeds of life on Earth. At cold temperatures, hydrogen cyanide forms crystals. And, according to computer models reported in ACS Central Science, some of the facets on these crystals are highly reactive, enabling chemical reactions that are otherwise not possible at low temperatures. The researchers say these reactions could have started a cascade that gave rise to several building blocks of life.
“We may never know precisely how life began, but understanding how some of its ingredients take shape is within reach. Hydrogen cyanide is likely one source of this chemical ...
Foams are everywhere: soap suds, shaving cream, whipped toppings and food emulsions like mayonnaise. For decades, scientists believed that foams behave like glass, their microscopic components trapped in static, disordered configurations.
Now, engineers at the University of Pennsylvania have found that foams actually flow ceaselessly inside while holding their external shape. More strangely, from a mathematical perspective, this internal motion resembles the process of deep learning, the method typically used to train modern AI systems.
The discovery could hint that learning, in a broad mathematical sense, may be a common organizing ...
Fluorophores are chemical compounds or molecules that absorb light energy at one wavelength and re-emit it as light at a longer, lower-energy wavelength, acting as glowing tags or markers. The absorption process is known as excitation, and the re-emission is visible as fluorescent light, which makes these molecules crucial for biological imaging, diagnostics, and tracing cellular molecules like proteins or lipids under normal or various infectious conditions.
Fluorophores with red-light absorption properties are ideal for bioimaging. Red light refers ...
Spinal deformities such as scoliosis and kyphosis are among the most serious complications of neurofibromatosis type 1 (NF1), a genetic disorder that affects about one in 3,000 people. These deformities often begin in childhood, worsen rapidly, and can lead to chronic pain, reduced mobility, and may require major surgery. Despite their frequency and severity, there are currently no approved drug treatments to prevent NF1-related spinal deformity.
In a new study published in Volume 13, Issue 103 of the journal Bone Research on December ...
Genetic disorders occur due to alterations in the primary genetic material, deoxyribonucleic acid (DNA), of an organism. Transthyretin amyloidosis (ATTR) is a progressive disorder involving amyloid deposits of misfolded transthyretin (TTR) proteins. The deposits, mainly affecting the heart and the nerves, can lead to symptoms like heart failure and neuropathy. While one of its two major forms is associated with age, the other one is hereditary, resulting from destabilizing mutations in the TTR gene. The therapeutic efficacy of suppressing TTR production has been clearly demonstrated. Although ribonucleic acid (RNA) interference-based ...
